Measuring continuous baseline covariate imbalances in clinical trial data

This paper presents and compares several methods of measuring continuous baseline covariate imbalance in clinical trial data. Simulations illustrate that though the t-test is an inappropriate method of assessing continuous baseline covariate imbalance, the test statistic itself is a robust measure in capturing imbalance in continuous covariate distributions. Guidelines to assess effects of imbalance on bias, type I error rate and power for hypothesis test for treatment effect on continuous outcomes are presented, and the benefit of covariate-adjusted analysis (ANCOVA) is also illustrated.

[1]  Wenle Zhao,et al.  Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization. , 2011, Contemporary clinical trials.

[2]  Alan Agresti,et al.  Categorical Data Analysis , 2003 .

[3]  D. Taves,et al.  Rank-Minimization for balanced assignment of subjects in clinical trials. , 2010, Contemporary clinical trials.

[4]  Andrea Manca,et al.  A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. , 2010, Journal of clinical epidemiology.

[5]  Testing for covariate balance using nonparametric quantile regression and resampling methods , 2009 .

[6]  P. Fayers,et al.  The baseline characteristics did not differ significantly , 2008, Quality of Life Research.

[7]  T. Louis,et al.  Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial , 2008, Clinical trials.

[8]  William F. Rosenberger,et al.  Handling Covariates in the Design of Clinical Trials. , 2008, 1102.3773.

[9]  J. Dumville,et al.  The impact of trial baseline imbalances should be considered in systematic reviews: a methodological case study. , 2007, Journal of clinical epidemiology.

[10]  J. Frey.  Recombinant Tissue Plasminogen Activator (rtPA) for Stroke: The Perspective at 8 Years , 2005, The neurologist.

[11]  Stanley Lemeshow,et al.  Multiple Logistic Regression , 2005 .

[12]  T. Louis,et al.  Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial , 2004, Stroke.

[13]  Ewout W Steyerberg,et al.  Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. , 2004, Journal of clinical epidemiology.

[14]  Jeffrey H Silber,et al.  Optimal multivariate matching before randomization. , 2004, Biostatistics.

[15]  Damian McEntegart,et al.  The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview , 2003 .

[16]  J. Matthews,et al.  Randomization in Clinical Trials: Theory and Practice; , 2003 .

[17]  S. Pocock,et al.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems , 2002, Statistics in medicine.

[18]  J. Norrie,et al.  The role of covariates in estimating treatment effects and risk in long‐term clinical trials , 2002, Statistics in medicine.

[19]  S. Green,et al.  Design of randomized trials. , 2002, Epidemiologic reviews.

[20]  Anthony C. Atkinson,et al.  The comparison of designs for sequential clinical trials with covariate information , 2002 .

[21]  G M Raab,et al.  How to select covariates to include in the analysis of a clinical trial. , 2000, Controlled clinical trials.

[22]  D. Harrington.  The Randomized Clinical Trial , 2000 .

[23]  C Roberts,et al.  Baseline imbalance in randomised controlled trials , 1999, BMJ.

[24]  W W Hauck,et al.  Should we adjust for covariates in nonlinear regression analyses of randomized trials? , 1998, Controlled clinical trials.

[25]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[26]  S. Senn.  Testing for baseline balance in clinical trials. , 1994, Statistics in medicine.

[27]  N. Jewell,et al.  Some surprising results about covariate adjustment in logistic regression models , 1991 .

[28]  S J Senn,et al.  Covariate imbalance and random allocation in clinical trials. , 1989, Statistics in medicine.

[29]  Stephen L. George,et al.  Fundamentals of Clinical Trials. (2nd ed.). , 1987 .

[30]  D. Altman.  Comparability of Randomised Groups , 1985 .

[31]  D. Rubin,et al.  Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score , 1985 .

[32]  M. Gail,et al.  Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates , 1984 .

[33]  E. Baráth,et al.  Fundamentals of Biostatistics. , 1992 .

[34]  A. Atkinson.  Optimum biased coin designs for sequential clinical trials with prognostic factors , 1982 .

[35]  C B Begg,et al.  A treatment allocation procedure for sequential clinical trials. , 1980, Biometrics.

[36]  P. Zarembka.  Frontiers in econometrics , 1973 .

[37]  D. Wolfe,et al.  Nonparametric Statistical Methods. , 1974 .